CRISPR-cas systems for genome editing
AssigneePioneer Hi-Bred International, Inc.
InventorsZhenglin Hou, Tautvydas Karvelis, Virginijus Siksnys, Joshua K Young
Life of this patent
Estimating the term…
Loading patent…
AssigneePioneer Hi-Bred International, Inc.
InventorsZhenglin Hou, Tautvydas Karvelis, Virginijus Siksnys, Joshua K Young
Estimating the term…
Compositions and methods are provided for genome modification of a target sequence in the genome of a cell, using a novel Cas endonuclease. The methods and compositions employ a guide polynucleotide/endonuclease system to provide an effective system for modifying or altering target sequences within the genome of a cell or organism. Also provided are novel effectors and endonuclease systems and elements comprising such systems, such as guide polynucleotide/endonuclease systems comprising an endonuclease. Compositions and methods are also provided for guide polynucleotide/endonuclease systems comprising at least one endonuclease, optionally covalently or non-covalently linked to, or assembled with, at least one additional protein subunit, and for compositions and methods for direct delivery of endonucleases as ribonucleotide proteins.
A synthetic composition comprising:
A synthetic composition comprising:
A method of introducing a targeted edit in a target polynucleotide, the method comprising:
Dependencies are inferred from the claim text.